EMA - High-quality data to empower data-driven medicines regulation in the European Union

19th October 2022

EMA

EMA and the Heads of Medicines Agencies (HMA) in the EU Member States are moving ahead with their ambitious agenda to increase access and improve the quality of the data that underpin decision-making on the benefits and risks of medicines in the European Union (EU).

Read More

Back to News Archive